[Treatment of chronic hepatitis B with interferon alpha-2b]. 1990

R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
Infektionsklinik des Städtischen Krankenhauses Berlin-Prenzlauer Berg, Berlin, DDR.

A total of 58 patients with histologically confirmed chronic viral hepatitis B and presence of HBsAg and HBV-DNA in the serum were randomized in a prospectively controlled trial. 30 patients were treated with 3 megaunits of rIFN a-2b s.c. thrice weekly for 4 months. 28 controls received no treatment. The post-treatment follow-up period consisted of 6 months. 28 patients treated and 27 controls completed the protocol. One female patient of the treatment group showed a complete response (loss of HBsAg, HBeAg and HBV-DNA), 8 other patients (32%) revealed a partial response to therapy (loss of HBeAg and HBV-DNA). Three patients of the control-group (11%) lost HBeAg and HBV-DNA spontaneously. This finding is statistically significant (p less than 0.05). The elimination of HBV-markers from the serum was associated with a normalization of aminotransferase activities in the serum. A reactivation of hepatitis was not observed after seroconversion.

UI MeSH Term Description Entries
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B

Related Publications

R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
July 2004, Journal of gastroenterology and hepatology,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
October 1996, Journal of tropical pediatrics,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
October 1992, Journal of chemotherapy (Florence, Italy),
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
May 1995, Annals of internal medicine,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
October 1996, American family physician,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
January 2005, European journal of dermatology : EJD,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
January 1991, Przeglad epidemiologiczny,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
March 2007, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
January 1992, Infection,
R Baumgarten, and R Müller, and R Markus, and B Hintsche-Kilger, and J D Fengler, and H Meisel
January 2003, World journal of gastroenterology,
Copied contents to your clipboard!